^
    No biomarker
    GBM
    Krabeva (bevacizumab biosimilar)
    Sensitive
    :
    A1
    Biocon Press Release - 2wk
    No biomarker
    GBM
    Byvasda (bevacizumab biosimilar)
    Sensitive
    :
    A1
    No biomarker
    Astrocytoma
    everolimus
    Sensitive
    :
    A1
    No biomarker
    Astrocytoma
    carmustine
    Sensitive
    :
    A1
    No biomarker
    Ependymoma
    carmustine
    Sensitive
    :
    A1
    No biomarker
    Anaplastic Astrocytoma
    temozolomide
    Sensitive
    :
    A1
    No biomarker
    GBM
    bevacizumab
    Sensitive
    :
    A1
    No biomarker
    Glioma
    carmustine
    Sensitive
    :
    A1
    No biomarker
    GBM
    temozolomide
    Sensitive
    :
    A1
    No biomarker
    GBM
    carmustine
    Sensitive
    :
    A1
    No biomarker
    GBM
    Zirabev (bevacizumab biosimilar)
    Sensitive
    :
    A1
    No biomarker
    GBM
    Mvasi (bevacizumab biosimilar)
    Sensitive
    :
    A1
    No biomarker
    GBM
    PCV
    Sensitive
    :
    A2
    No biomarker
    Anaplastic Astrocytoma
    PCV
    Sensitive
    :
    A2
    No biomarker
    Glioma
    PCV
    Sensitive
    :
    A2
    MGMT promoter methylation
    GBM
    temozolomide
    Sensitive
    :
    A2
    No biomarker
    Oligodendroglioma
    temozolomide
    Sensitive
    :
    A2
    No biomarker
    Glioma
    temozolomide
    Sensitive
    :
    A2
    BRAF V600E
    Ganglioglioma
    trametinib + dabrafenib
    Sensitive
    :
    A2
    No biomarker
    Glioma
    bevacizumab
    Sensitive
    :
    A2
    BRAF V600E
    Ganglioglioma
    vemurafenib + cobimetinib
    Sensitive
    :
    A2
    BRAF V600E
    Ganglioglioma
    vemurafenib
    Sensitive
    :
    A2
    BRAF V600E
    Astrocytoma
    trametinib + dabrafenib
    Sensitive
    :
    A2
    No biomarker
    Astrocytoma
    lomustine + procarbazine hydrochloride + vincristine liposomal
    Sensitive
    :
    A2
    No biomarker
    GBM
    lomustine
    Sensitive
    :
    A2
    VERI is free for non-commercial use, no login needed.
    Content on this site is for research purposes only and is not intended  to be a substitute for medical advice.
    For commercial access, including additional premium features, please contact us.
    By using VERI, you are agreeing to our
    and
    Privacy Policy
    ACCEPT COOKIES